You are here
- Home
- Therapy Areas
- Cardiovascular
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) A 104-Week, Open-label, Multi-center, Phase IIIb Study Evaluating the Effect of Treatment with Rosuvastatin 40 mg on Atherosclerotic Disease as Measured by Intravascular Ultrasound and Quantitative Coronary Angiography in Subjects Undergoing Coronary Angiography who have Coronary Artery Disease
- Disease
- hypercholesterolaemia
- Drug Name
- Crestor
- Generic Name
- rosuvastatin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- Jan 18, 1971
- Study Name
- 4522IL/0076
- Study Id
- 4522IL/0076
- ClinicalTrials.gov ID
- NCT00240318
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
